Correlation Between ACCSYS TECHPLC and Syndax Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ACCSYS TECHPLC and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACCSYS TECHPLC and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ACCSYS TECHPLC EO and Syndax Pharmaceuticals, you can compare the effects of market volatilities on ACCSYS TECHPLC and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACCSYS TECHPLC with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACCSYS TECHPLC and Syndax Pharmaceuticals.

Diversification Opportunities for ACCSYS TECHPLC and Syndax Pharmaceuticals

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between ACCSYS and Syndax is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding ACCSYS TECHPLC EO and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and ACCSYS TECHPLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACCSYS TECHPLC EO are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of ACCSYS TECHPLC i.e., ACCSYS TECHPLC and Syndax Pharmaceuticals go up and down completely randomly.

Pair Corralation between ACCSYS TECHPLC and Syndax Pharmaceuticals

Assuming the 90 days horizon ACCSYS TECHPLC EO is expected to generate 0.47 times more return on investment than Syndax Pharmaceuticals. However, ACCSYS TECHPLC EO is 2.12 times less risky than Syndax Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  59.00  in ACCSYS TECHPLC EO on September 20, 2024 and sell it today you would lose (7.00) from holding ACCSYS TECHPLC EO or give up 11.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ACCSYS TECHPLC EO  vs.  Syndax Pharmaceuticals

 Performance 
       Timeline  
ACCSYS TECHPLC EO 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ACCSYS TECHPLC EO has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Syndax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

ACCSYS TECHPLC and Syndax Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ACCSYS TECHPLC and Syndax Pharmaceuticals

The main advantage of trading using opposite ACCSYS TECHPLC and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACCSYS TECHPLC position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.
The idea behind ACCSYS TECHPLC EO and Syndax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories